VRTX

Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
$541.69
-5.86 (-1.07%)
Mkt Cap: 137.48B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield2.8%
Dividend YieldN/A
Market Cap137.48B
Volume886.8K
Recent News
Ancora Advisors LLC Acquires Shares of 1,127 Vertex Pharmaceuticals Incorporated $VRTX
defenseworld.net · 2026-08-29
17,047 Shares in Vertex Pharmaceuticals Incorporated $VRTX Acquired by Beacon Pointe Advisors LLC
defenseworld.net · 2026-08-29
Breakfast News: Nvidia Crushed It. Who Cares?
fool.com · 2026-08-27
Vertex to Participate in Upcoming September Investor Conferences
businesswire.com · 2026-08-26
EP Wealth Advisors LLC Acquires New Position in Vertex Pharmaceuticals Incorporated $VRTX
defenseworld.net · 2026-08-23
Advisors Capital Management LLC Buys Shares of 1,258 Vertex Pharmaceuticals Incorporated $VRTX
defenseworld.net · 2026-08-22

Unlock the Full Deep Scan

9 AI agents analyze VRTX across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →